NCT06729203 Effect of Ultrasound Cavitation on Insulin Resistance in Patients with Central Obesity in Female
| NCT ID | NCT06729203 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Central Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 52 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 52 participants in total. It began in 2024-12-01 with a primary completion date of 2025-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study was to investigate the effect of ultrasound cavitation on insulin resistance, HbA1c and skin fold in patients with abdominal central obesity.
Eligibility Criteria
Inclusion Criteria: * Female subjects with central obesity. * Female participants aged between 25 to 40 years. * Body Mass Index (BMI) ranged from 30 to 35 kg/m2 as high BMI indicates more obesity and central obesity. * Waist circumference greater than 88 cm, indicative of abdominal obesity. * Diagnosed with insulin resistance (HOMA-IR \> 2.9). * Sedentary lifestyle, defined as engaging in less than 150 minutes of moderate-intensity physical activity per week. * Willingness to provide informed consent and comply with study procedures. Exclusion Criteria: * • Subjects diagnosed with DM (HbA1c more than 6.5%). * History of metabolic disorders such as type 1 diabetes or thyroid disorders. * Subjects with BMI less than 30 kg/m2. * Subjects diagnosed with heart disease, liver as well as kidney diseases. * Subjects who take oral contraceptives. * Subjects with gestational Diabetes. * Pregnant or breastfeeding women were excluded from the study. * Use of weight-loss medications or supplements within the past six months. * Previous surgical procedures for weight loss or body contouring. * Contraindications to ultrasound therapy (e.g., metal implants in the abdomen, active skin infections). * Participation in another clinical trial within the last three months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06729203 clinical trial?
This trial is open to female participants only, aged 25 Years or older, up to 40 Years, studying Central Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06729203 currently recruiting?
Yes, NCT06729203 is actively recruiting participants. Contact the research team at aya_saeedpt@yahoo.com for enrollment information.
Where is the NCT06729203 trial being conducted?
This trial is being conducted at Giza, Egypt.
Who is sponsoring the NCT06729203 clinical trial?
NCT06729203 is sponsored by Cairo University. The trial plans to enroll 52 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.